Tekla Life Sciences Investors (HQL) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Tekla Life Sciences Inves...

NYSE: HQL · Real-Time Price · USD
16.46
0.25 (1.54%)
At close: Oct 15, 2025, 3:59 PM
16.45
-0.06%
After-hours: Oct 15, 2025, 06:21 PM EDT

Tekla Life Sciences Investors Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
22.35M -104.6K 64.53K
Depreciation & Amortization
n/a n/a n/a
Deferred Income Tax
n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a
Change in Working Capital
n/a n/a n/a
Accounts Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Accounts Payables
n/a n/a n/a
Other Working Capital
n/a n/a n/a
Other Non-Cash Items
-22.35M 104.6K -64.53K
Net Cash from Operating Activities
n/a n/a n/a
Operating Cash Flow
n/a n/a n/a
PP&E Investments
n/a n/a n/a
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities of Investments
n/a n/a n/a
Other Investing Activities
n/a n/a n/a
Net Cash from Investing Activities
n/a n/a n/a
Net Debt Issuance
n/a n/a n/a
Long-Term Net Debt Issuance
n/a n/a n/a
Short-Term Net Debt Issuance
n/a n/a n/a
Net Stock Issuance
n/a n/a n/a
Net Common Stock Issuance
n/a n/a n/a
Common Stock Issuance
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Net Preferred Stock Issuance
n/a n/a n/a
Net Dividends Paid
n/a n/a n/a
Common Dividends Paid
n/a n/a n/a
Preferred Dividends Paid
n/a n/a n/a
Other Financing Activities
n/a n/a n/a
Net Cash from Financing Activities
n/a n/a n/a
Effect of Forex Changes on Cash
n/a n/a n/a
Net Change in Cash
32.00 -545 n/a
Cash at End of Period
477.00 445.00 n/a
Cash at Beginning of Period
445.00 990.00 1.12M
Free Cash Flow
n/a n/a n/a
Income Taxes Paid
n/a n/a n/a
Interest Paid
n/a n/a n/a
Source: Financial Modeling Prep. Financial Sources.
SEC Filings: 10-K · 10-Q